Amar Singh has been appointed executive vice president and chief business officer at Sorrento Therapeutics. Mr. Singh will be responsible for overseeing partnering activities. He has more than 25 years of experience in business and commercial development, strategic planning and operations.   Mr. Singh joins the company from Synta Pharmaceuticals, where he served as senior vice president and chief business officer, responsible for leading business and commercial development, clinical operations, ...